Simplify Asset Management’s Edwards Lifesciences EW Stock Holding History

Simplify Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Buy	18,668 +4,590	+33%	+$385K	0.02%	65
2026 Q1	$1.13M	Sell	14,078 -5,260	-27%	-$434K	0.02%	69
2025 Q4	$1.65M	Buy	19,338 +9,284	+92%	+$762K	0.03%	72
2025 Q3	$782K	Buy	10,054 +1,224	+14%	+$95.6K	0.01%	88
2025 Q2	$691K	Sell	8,830 -969	-10%	-$72.3K	0.03%	69
2025 Q1	$710K	Sell	9,799 -70,959	-88%	-$5.08M	0.03%	69
2024 Q4	$5.98M	Buy	+80,758	New	+$5.65M	0.3%	24
2022 Q1	–	Sell	-3,234	Closed	-$419K	–	100
2021 Q4	$419K	Buy	+3,234	New	+$377K	0.02%	50

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Simplify Asset Management's EW Position: Q2 2026 in Review

Simplify Asset Management increased its Edwards Lifesciences (EW) stake by 33% in Q2 2026, buying an estimated $385K and bringing the position to 18,668 shares worth $1.69M. The position accounts for 0.02% of the portfolio, ranked #65.

Simplify Asset Management first reported a position in EW in Q4 2021 and has held it in 8 quarters since. The position peaked at $5.98M in Q4 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Simplify Asset Management held 18,668 shares of Edwards Lifesciences worth $1.69M as of Q2 2026.
Simplify Asset Management bought 4,590 Edwards Lifesciences shares in Q2 2026, an estimated $385K.
Edwards Lifesciences made up 0.02% of Simplify Asset Management's portfolio in Q2 2026, its #65 holding.
Simplify Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 8 quarters since.
Simplify Asset Management's Edwards Lifesciences position peaked at $5.98M in Q4 2024.
774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.